Ken Ishiyama

31PUBLICATIONS
93CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursHaematologyRegenerative medicine (incl. stem cells)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (31)

|Jan 04, 2026
Phase II study of the triple combination of rabbit ATG, ciclosporin and eltrombopag in patients with transfusion-dependent aplastic anaemia: West Japan Hematology Study Group (W-JHS) AA02 trial.

Fumi Nakamura, Ken Ishiyama, Ritsuro Suzuki

|Sep 08, 2025
Efficacy of ciclosporin monotherapy in non-severe aplastic anaemia not requiring transfusions: Results from a multicentre phase II study.

Ken Ishiyama, Masahide Yamazaki, Hiroyuki Maruyama

|Aug 19, 2024
Haematopoietic regeneration by HLA-A*0206-deficient clones in severe aplastic anaemia without definitive immunosuppressive treatment.

Yoshitaka Zaimoku, Kazuya Sakai, Noriaki Tsuji

|Feb 08, 2024
Updated comparable efficacy of cord blood transplantation for chronic myelomonocytic leukaemia: a nationwide study.

Shuhei Kurosawa, Yoshimitsu Shimomura, Ken Ishiyama

|Nov 08, 2023
Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCT.

Noriharu Nakagawa, Ken Ishiyama, Kensuke Usuki

|Nov 08, 2023
Minor GPI(-) granulocyte populations in aplastic anemia and healthy individuals derived from a few PIGA-mutated hematopoietic stem progenitor cells.

Hiroki Mizumaki, Dung Cao Tran, Kohei Hosokawa

Pageof 6

Frequent Collaborators

9 joint publications

Shinji Nakao

7 joint publications

Yoshiko Atsuta

6 joint publications

Junya Kanda

6 joint publications

Kohei Hosokawa